{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:08:01Z","timestamp":1778659681503,"version":"3.51.4"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Background:<\/jats:bold> Paroxysmal atrial fibrillation (PAF) transits to permanent atrial fibrillation (PEAF). The current study was to determine whether a P wave\u2010triggered P wave signal averaged electrocardiogram (P\u2010SAECG) and chemoreflexsensitivity (CHRS) are useful to predict a conversion to PEAF in patients with PAF.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Methods:<\/jats:bold> The filtered P wave duration (FPD) and the root mean square voltage of the last 20 ms of the P wave (RMS 20) were measured by P\u2010SAECG. The ratio between the difference of RR intervals in the ECG and venous pO2 before and after 5\u2010minutes oxygen inhalation is measured (ms\/mmHg) for the determination of CHRS.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Results:<\/jats:bold> A total of 180 patients with PAF were enrolled and followed for a mean of 22.5 months. PEAF occurred in 38 patients (21%) and these patients had a significantly larger left atrial size (43.2 \u00b1 4.9 vs. 41.0 \u00b1 5.4 mm, P = 0.021), a significantly longer FPD (158.8 \u00b1 18.2 vs. 136.7 \u00b1 16.6 ms, P &lt; 0.0001), and a significantly lower CHRS (1.96 \u00b1 0.99 vs. 2.44 \u00b1 1.19 ms\/mmHg, P = 0.024) than patients with PAF. Patients with PEAF tended to have a lower RMS 20 (2.38 \u00b1 0.65 vs. 2.75 \u00b1 1.18 \u03bcV, P = 0.067) than patients with PAF. The \u03c7<jats:sup>2<\/jats:sup> test showed that the combination of FPD \u2265 145 ms, RMS 20 \u22643.0 \u03bcV, left atrial size \u2265 41 mm, and CHRS \u22642.0 ms\/mmHg had the best predictive power for PEAF. Patients who fulfilled these criteria had a 12\u2010fold increased risk for a conversion from PAF to PEAF.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusions:<\/jats:bold> Our results show that a P\u2010SAECG, an analysis of CHRS, and left atrial enlargement are clinical predictors of a progression from PAF to PEAF.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2007.00656.x","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:21:18Z","timestamp":1172708478000},"page":"243-252","source":"Crossref","is-referenced-by-count":18,"title":["Prediction of Conversion from Paroxysmal to Permanent Atrial Fibrillation"],"prefix":"10.1111","volume":"30","author":[{"given":"MARCO","family":"BUDEUS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OLIVER","family":"FELIX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCUS","family":"HENNERSDORF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEINRICH","family":"WIENEKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAIMUND","family":"ERBEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEFAN","family":"SACK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198204293061703"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.17.4.622"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709103171104"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/15.suppl_A.9"},{"key":"e_1_2_7_7_2","first-page":"293","article-title":"Efficacy of \u03b2\u2010blockade for prevention of paroxysmal atrial fibrillation evaluation by baroreflexsensitivity","volume":"14","author":"Yamaguchi I","year":"1993","journal-title":"Eur Heart J"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/cvr\/8.5.647","article-title":"Effects of selective vagal or stellate ganglion on atrial refractoriness","volume":"8","author":"Zipes DP","year":"1974","journal-title":"Cardiovasc Res"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.079"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.12.001"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.12.062"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/eupace\/7.Supplement_1.133-a","article-title":"Prediction of recurrence of atrial fibrillation after successful cardioversion with chemoreflexsensitivity and P wave signal averaged ECG: A 12 months follow up of 118 patients","volume":"7","author":"Budeus M","year":"2005","journal-title":"Europace"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eul097"},{"key":"e_1_2_7_14_2","first-page":"115","article-title":"Efficacy of class Ic antiarrhythmic drugs predicted by P wave signal averaged ECG in patients with paroxysmal atrial fibrillation","volume":"7","author":"Aspromonte N","year":"1994","journal-title":"J Amb Monitoring"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2000.tb00827.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90597-4"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.8.2612"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4950250206"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00718-0"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oxfordjournals.eurheartj.a061002","article-title":"Low vagal tone and supraventricular ectopic activity predict atrial fibrillation and flutter after coronary artery bypass grafting","volume":"16","author":"Frost L","year":"1995","journal-title":"Eur Heart J"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2003.02462.x"},{"key":"e_1_2_7_22_2","first-page":"183","article-title":"On the multiple wavelet hypothesis of atrial fibrillation","volume":"140","author":"Moe GK","year":"1962","journal-title":"Arch Intern Pharmacodyn"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.7.1954"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1998.tb01197.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80022-8"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.03.010"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.09.053"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.87"},{"key":"e_1_2_7_29_2","first-page":"II8","article-title":"The effect of antiarrhythmic medication on the variables of P wave signal averaged ECG among paroxysmal atrial fibrillation","volume":"92","author":"Budeus M","year":"2003","journal-title":"Z Kardiol"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00792-9"},{"key":"e_1_2_7_31_2","first-page":"V85","article-title":"Increase of the chemoreflexsensitivity by \u03b2\u2010blocker therapy among adrenergically caused paroxysmal atrial fibrillation","volume":"91","author":"Budeus M","year":"2002","journal-title":"Z Kardiol"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041705"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.1.224"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2007.00656.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2007.00656.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:22:05Z","timestamp":1697170925000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2007.00656.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1540-8159.2007.00656.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2007.00656.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}